Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background: FIND, the global alliance for diagnostics, identified the nonmarket-approved continuous glucose monitoring (CGM) system, FiberSense system (FBS), as a potential device for use in low- and middle-income countries. Together with two market-approved, factory-calibrated CGM systems, namely, the FreeStyle Libre 2 (FL2) and the GlucoRx AiDEX (ADX), the FBS was subjected to a clinical performance evaluation. Methods: Thirty adult participants with type 1 diabetes were enrolled. The study was mainly conducted at home, with three in-clinic sessions conducted over the study period of 28 days. Comparator measurements were collected from capillary samples, using a high-quality blood glucose monitoring system. Results: Data from 31, 70, and 78 sensors of FBS, FL2, and ADX, respectively, were included in the performance analysis. The mean absolute relative differences between CGM and comparator data for FBS, FL2, and ADX were 14.7%, 9.2%, and 21.9%, and relative biases were −2.1%, −2.5%, and −18.5%, respectively. Analysis of individual sensor accuracy revealed low, moderate, and high sensor-to-sensor variability for FBS, FL2, and ADX, respectively. Sensor survival probabilities until the end of sensor life were 47.2% for FBS (28 days), 71.3% for FL2 (14 days), and 48.4% for ADX (14 days). Conclusions: The results of FBS were encouraging enough to conduct further performance and usability evaluations in a low- and middle-income country. The results of FL2 mainly agreed with existing studies, whereas ADX showed substantial deviations from previously reported results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, accuracy studies published in peer-reviewed journals are not available for some devices, and the result is that their pivotal accuracy studies for regulatory clearance might not be replicated in independent studies.32,33”
From Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring (2025) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, a lack of information on study design, or limitations in published studies for some devices limits critical evaluation of accuracy data, with the result that the reported accuracy of non-iCGM-approved devices might not be replicated in independent studies.33,38”
From Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring (2025) · cites this paper as [33]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“By contrast, the manufacturers of many non-iCGM-approved devices sold outside the United States have not published robust accuracy data or randomized controlled trial data to support their use.”
From Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring (2025) · cites this paper as [33]
Experimental — accuracy not yet measuredIn the citing paper
“For instance, accuracy studies published in peer-reviewed journals are not available for some devices, and the result is that their pivotal accuracy studies for regulatory clearance might not be replicated in independent studies.32,33”
From Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring (2025) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors
Kovatchev, B. P., Gonder-Frederick, L. A., Cox, D. J., & Clarke, W. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1922 · Cited by 312 · cited 1×
“14 The R-EGA assigns every pair of comparator and CGM RoCs to risk zones A to E, depending on their difference.”
BackgroundHeinemann, L., Schoemaker, M., Schmelzeisen-Redecker, G., Hinzmann, R., Kassab, A., Freckmann, G., Reiterer, F., & Del Re, L. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819855670 · Cited by 170 · cited 1×
“Our study shows that the in-development FBS demonstrated promising accuracy results, comparable to earlier generation CGM, 17 with the added advantage of a 28-day sensor lifetime.”
Self-citationAlva, S., Bailey, T., Brazg, R., Budiman, E. S., Castorino, K., Christiansen, M. P., Forlenza, G., Kipnes, M., Liljenquist, D. R., & Liu, H. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820958754 · Cited by 164 · cited 3×
“Results of the established, market-approved FL2 largely agreed with the previous study 8 ; however, the importance of assessing individual sensor accuracy was highlighted.”
MethodResultInfluentialElbalshy, M., Haszard, J., Smith, H., Kuroko, S., Galland, B., Oliver, N., Shah, V., de Bock, M. I., & Wheeler, B. J. (2022) · Diabetic Medicine · doi:10.1111/dme.14854 · Cited by 104
Shang, T., Zhang, J. Y., Thomas, A., Arnold, M. A., Vetter, B. N., Heinemann, L., & Klonoff, D. C. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211007212 · Cited by 71
Self-citationMüller, A. J., Knuth, M., Nikolaus, K. S., Krivánek, R., Küster, F., & Hasslacher, C. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700103 · Cited by 37 · cited 2×
“At the end of this process, one device, the FiberSense CGM system (FBS; EyeSense GmbH, Großostheim, Germany), 5,6 was chosen for the initial performance study.”
MethodResultInfluentialJi, L., Guo, L., Zhang, J., Li, Y., & Chen, Z. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211037991 · Cited by 26 · cited 1×
“For the newer, market-approved ADX, the results were markedly different in comparison with a previous study 7 and indicated lower performance.”
ResultImproving the Bias of Comparator Methods in Analytical Performance Assessments Through Recalibration
Pleus, S., Eichenlaub, M., Gerber, T., Eriksson Boija, E., Makris, K., Haug, C., & Freckmann, G. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221133107 · Cited by 24
Self-citationEichenlaub, M., Stephan, P., Waldenmaier, D., Pleus, S., Rothenbühler, M., Haug, C., Hinzmann, R., Thomas, A., JENDLE, J. H., Diem, P., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221134639 · Cited by 23 · cited 1×
“11 Furthermore, the mean absolute relative differences (MARDs) and agreement rates (ARs) between CGM and comparator pairs were calculated.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Clinical Laboratory Standards Institute. POCT05—Performance Metrics for Continuous Interstitial Glucose Monitoring. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
Cited by
Freckmann, G., Eichenlaub, M., Waldenmaier, D., Pleus, S., Wehrstedt, S., Haug, C., Witthauer, L., Jendle, J., Hinzmann, R., Thomas, A., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231190941 · Cited by 86
“164 An example of such an examination can be found in a recent study by Kölle et al, 167 which was excluded from this review because it was published in 2023.”
BackgroundSelf-citationTauschmann, M., Cardona‐Hernandez, R., DeSalvo, D. J., Hood, K. K., Лаптев, Д. Н., Olinder, A. L., Wheeler, B. J., & Smart, C. E. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543156 · Cited by 82
“The AGP requires suf fi cient collection of CGM data with studies indicating that 14 consecutive days of CGM use with at least 70% data capture will adequately represent glycemic patterns to make therapy adjustments [161, 162].”
Klonoff, D. C., Gabbay, M., Moon, S. J., & Wilmot, E. G. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241250357 · Cited by 36
“32,33 A published article might not be relevant to performance in situations specified by the product label because it might include testing in a study population that exceeds the age range of the population for whom the product is approved, or the range of glucose concentrations tested might be…”
Oganesova, Z., Pembérton, J. H., & Brown, A. C. (2024) · Diabetic Medicine · doi:10.1111/dme.15369 · Cited by 30
Freckmann, G., Pleus, S., Eichenlaub, M., Boija, E. E., Fokkert, M. J., Hinzmann, R., JENDLE, J. H., Klonoff, D. C., Makris, K., Nichols, J. H., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251336221 · Cited by 23
Self-citation
Metadata
- Authors
- Kölle, J., Eichenlaub, M., Mende, J., Link, M., Vetter, B., Safary, E., Pleus, S., Haug, C., & Freckmann, G.
- Affiliations
- Universität Ulm (DE)
- FIND (CH)
- Corresponding author
- Eichenlaub, Manuel
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2023-02-22
- Volume
- 18
- Issue
- 6
- Pages
- 1424-1432
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC11529083
- OpenAlex
- W4321497539
- Cited by
- 9
- References
- 14
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 1
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (unspecified)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- FIND
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Physical Sciences › Chemistry › Analytical Chemistry › Electrochemical sensors and biosensors
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- continuous glucose monitoring, type 1 diabetes, FreeStyle Libre 2, sensor accuracy, low- and middle-income countries, device performance evaluation
- MeSH terms
- Continuous Glucose Monitoring, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Male, Middle Aged, Blood Glucose Self-Monitoring, Reproducibility of Results, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes. https://app.cochat.ai/papers/10.1177/19322968231159657
- The paper
- Kölle, J., Eichenlaub, M., Mende, J., Link, M., Vetter, B., Safary, E., Pleus, S., Haug, C., & Freckmann, G. (2024). Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968231159657
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.